- Filed
- Aug 22, 2024 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Aug 19, 2024 | 330.48M sh |
| Shares Diluted | Q2 2024 · Mar 31, 2024 | 330.48M sh |
| Shares Diluted | Q2 2024 · Mar 31, 2024 | 330.48M sh |
| Shares Diluted | Q2 2024 · Mar 31, 2023 | 330.48M sh |
| Shares Diluted | Q2 2024 · Mar 31, 2023 | 330.48M sh |
| Operating Cash Flow | Q2 2024 · Mar 31, 2024 | −$2.17K |
| Operating Cash Flow | Q2 2024 · Mar 31, 2023 | −$18.82K |
| Stockholders Equity | Q2 2024 · Mar 31, 2024 | −$113.14K |
| Stockholders Equity | Q2 2024 · Dec 31, 2023 | −$91.81K |
| Stockholders Equity | Q2 2024 · Sep 30, 2023 | −$91.31K |
| Stockholders Equity | Q2 2024 · Mar 31, 2023 | −$78.72K |
| Stockholders Equity | Q2 2024 · Dec 31, 2022 | −$70.63K |
| Stockholders Equity | Q2 2024 · Sep 30, 2022 | −$60.19K |
| Current Liabilities | Q2 2024 · Mar 31, 2024 | $113.14K |
| Current Liabilities | Q2 2024 · Sep 30, 2023 | $91.31K |
| Total Liabilities | Q2 2024 · Mar 31, 2024 | $113.14K |
| Total Liabilities | Q2 2024 · Sep 30, 2023 | $91.31K |
| Eps Diluted | Q2 2024 · Mar 31, 2024 | $0.00 |
| Eps Diluted | Q2 2024 · Mar 31, 2024 | $0.00 |
| Eps Diluted | Q2 2024 · Mar 31, 2023 | $0.00 |
| Eps Diluted | Q2 2024 · Mar 31, 2023 | $0.00 |
| Eps Basic | Q2 2024 · Mar 31, 2024 | $0.00 |
| Eps Basic | Q2 2024 · Mar 31, 2024 | $0.00 |
| Eps Basic | Q2 2024 · Mar 31, 2023 | $0.00 |
| Eps Basic | Q2 2024 · Mar 31, 2023 | $0.00 |
| Sga Expense | Q2 2024 · Mar 31, 2024 | $21.33K |
| Sga Expense | Q2 2024 · Mar 31, 2024 | $21.84K |
| Sga Expense | Q2 2024 · Mar 31, 2023 | $8.09K |
| Sga Expense | Q2 2024 · Mar 31, 2023 | $18.54K |
| Net Income | Q2 2024 · Mar 31, 2024 | −$21.33K |
| Net Income | Q2 2024 · Mar 31, 2024 | −$21.84K |
| Net Income | Q2 2024 · Mar 31, 2023 | −$8.09K |
| Net Income | Q2 2024 · Mar 31, 2023 | −$18.54K |
| Operating Income | Q2 2024 · Mar 31, 2024 | −$21.33K |
| Operating Income | Q2 2024 · Mar 31, 2024 | −$21.84K |
| Operating Income | Q2 2024 · Mar 31, 2023 | −$8.09K |
| Operating Income | Q2 2024 · Mar 31, 2023 | −$18.54K |